For almost twenty years, the Maryland Technology Development Corporation, otherwise known as TEDCO, has been the state’s s lead source for business assistance and seed funding for the development of startup companies.
The Daily Record has announced its 2017 Innovators of the Year, 26 individuals and companies who have created new products, services or programs that have had a positive effect on business, industry or the community.
A funding provider of new tech firms and a unit of one of the nation’s largest African American banks is offering black entrepreneurs up to $40,000 each to launch a tech company in Maryland.
Three local startups will receive up to $40,000 each in investments from the Maryland Technology Development Corp. and Harbor Bank as part of a new fund specifically targeted at black business owners.
After 14 months and two separate searches, the hunt for a new CEO of Maryland Technology Development Corp. has ended and George Davis is ready to take the helm.
The Maryland Technology Development Corp. has tapped as its new chief executive an investor with a track record of leading Baltimore-area startup companies.
George Davis, who ran Gemstone Biotherapeutics, brings experience running and investing in early stage startups. TEDCO’s board chairman called him an “entrepreneur’s entrepreneur.”
George Davis (Photo courtesy of TEDCO) George Davis has been appointed CEO of TEDCO, the technology development corporation announced Wednesday morning.
TEDCO has announced its 2017 ICE award recipients, and two of the six winners have connections to Johns Hopkins. On May 25, AsclepiX CEO Wendy Perrow was named entrepreneur of the year, and Glyscend received an award for innovation.
Maryland Technology Development Corp. is offering $300,000 to the person or organization that comes up with the best idea for how to support and grow technology companies in the state.
TEDCO’s ICE awards returned to Columbus Center in Inner Harbor on Thursday night. The Maryland agency, which provides resources for startups and other businesses, awards portfolio companies for Innovation, Corporate Excellence and Entrepreneurship.
The Maryland Stem Cell Research Commission has awarded $8.5 million to 29 projects that will explore how human stem cells can regenerate heart tissue, treat muscular dystrophy and sickle cell disease, and aid diabetes management, among other medical conditions.
The Maryland Stem Cell Research Commission has approved awards of more than $8.5 million for companies and research institutes to address more than 20 diseases and conditions. The money will be spread among six companies and six research institutes in the state.
